Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives

This publication has 16 references indexed in Scilit:

• Isoelectric-focusing patterns of cyclic nucleotide phosphodiesterase from rat heart
  Biochemical Journal, 1981
• Cyclic nucleotide phosphodiesterase from a particulate fraction of rat heart. Solubilization and characterization of a single enzymatic form
  Biochemical and Biophysical Research Communications, 1981
• The epinephrine‐induced activation of the cardiac slow Ca²⁺ channel is mediated by the cAMP‐dependent phosphorylation of calciductin, a 23 000 M_r sarcolemmal protein
  FEBS Letters, 1981
• Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds
  Biochemical Pharmacology, 1981
• Role of calcium and cyclic adenosine 3′:5′ monophosphate in regulating smooth muscle contraction: Mechanisms of excitation-contraction coupling in smooth muscle
  The American Journal of Cardiology, 1979
• The inotropic effects of UK 14,275, a phosphodiesterase inhibitor, in man.
  Published by Wiley ,1978
• Inhibition of heart and brain cvclic adenosine 3′,5′-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides
  Biochemical Pharmacology, 1978
• Are increases in cyclic GMP levels responsible for the negative inotropic effects of acetylcholine in the heart?
  Biochemical and Biophysical Research Communications, 1977
• Angiotensin antagonism and antihypertensive activity of phosphodiesterase inhibiting agents
  Life Sciences, 1973
• Molecular Order of Participation of Inhibitors (or Activators) in Biological Systems
  Science, 1969